Work

Pos-100 Outpatient Pharmacologic Treatments for Raas Inhibitor-related Hyperkalemia and the Risk of Recurrence

Year: 2021

Type: article

Abstract: Hyperkalemia commonly occurs with RAAS inhibitor (RAASi) use and associates with increased morbidity and mortality. The optimal ambulatory management of RAASi-related hyperkalemia to reduce the risk of recurrence is unknown.

Source: Kidney International Reports

DOI: 10.1016/j.ekir.2021.03.108

Authors: G. HUNDEMER, R. Talarico, M. Sood

Institutions: Ottawa Hospital, Institute for Clinical Evaluative Sciences, Ottawa Hospital Research Institute

Language: English

Topic: Potassium and Related Disorders

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,625

OpenAlex ID: W3153460271

FWCI:

Cites:

Cited by:

Related to: 10